The Business of RNAi Therapeutics

This publication has 26 references indexed in Scilit:

• A protocol for designing siRNAs with high functionality and specificity
  Nature Protocols, 2007
• Interfering with disease: a progress report on siRNA-based therapeutics
  Nature Reviews Drug Discovery, 2007
• Molecular biology of PCSK9: its role in LDL metabolism
  Trends in Biochemical Sciences, 2007
• Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
  Nature, 2006
• Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
  Nature Medicine, 2005
• Inhibition of respiratory viruses by nasally administered siRNA
  Nature Medicine, 2004
• Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant Rat P2X3 receptor
  Nucleic Acids Research, 2003
• The price of innovation: new estimates of drug development costs
  Journal of Health Economics, 2003
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
  Nature, 2001
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
  Nature, 1998